Intact proinsulin, des 31,32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes

Diabetes Care

Volumn 21, Issue 1, 1998, Pages 127-133

  Nagi, Dinesh K ^a,c   Knowler, William C ^a   Mohamed Ali, Vidya ^b   Bennett, Peter H ^a   Yudkin, John S ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c PINDERFIELDS GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DES 31,32 PROINSULIN; GLUCOSE; INSULIN; PROINSULIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERINSULINEMIA; INDIAN; INSULIN RELEASE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; RISK FACTOR; SOUTH ASIA;

EID: 0031985027     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.1.127     Document Type: Article

References (41)

1. King H, Rewers M, on behalf of the WHO Ad Hoc Diabetes Reporting Group: Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 16:216-227, 1993
2. Steiner DF, Oyer P: The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Nat Acad Sci USA 57:473-480, 1967
3. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y: Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (NIDDM) diabetes. Diabetologia 30:355-360, 1988
4. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D: Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30:698-702, 1987
5. Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowler WC, Schwartz MW, Kowalyk S, Bennett PH, Porte D Jr: Disproportionately elevated proinsulin in Pima Indians with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 70:1247-1253, 1990
6. Nagi DK, Hendra TJ, Ryle AJ, Cooper TM, Temple RC, Clark PMS, Schneider AE, Hales CN, Yudkin JS: The relationship between concentrations of insulin, intact proinsulin, and 32-33 split proinsulin and cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 33:532-537, 1990
7. Leahy JL: Increased proinsulin/insulin ratio in pancreas extracts of hyperglycemic rats. Diabetes 42:22-27, 1993
8. Leahy JL, Halban PA, Weir GC: Relative hypersecretion of proinsulin in rat model of NIDDM. Diabetes 40:985-989, 1991
9. DeFronzo RA: Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 35:389-397, 1992
10. Gerich JE: Role of insulin resistance in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus. Clin Endocrinol Metab 2:307-326, 1988
11. Turner RC, Holman RR, Matthews DR, Peto J: Relative contributions of insulin deficiency and insulin resistance in maturity-onset diabetes. Lancet i:596-598, 1982
12. Lillioja S, Mott D, Spraul M, Ferraro R, Foley J, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329:1988-1992, 1993
13. Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, Hales CN: Insulin deficiency in non-insulin-dependent diabetes. Lancet i:293-295, 1989
14. Groop L, Miettinen A, Groop PH, Meri S, Koskimies S, Bottazzo GF: Organ-specific autoimmunity and HLA-DR antigen as markers for β-cell destruction in patients with type II diabetes. Diabetes 37:99-103, 1988
15. Zimmet PZ: Hyperinsulinemia: how innocent a bystander? Diabetes Care 16:56-70, 1993
16. Knowler WC, Pettitt DJ, Saad MF, Bennett PH: Diabetes mellitus in the Pima Indians: incidence, risk factors, and pathogenesis. Diabetes Metab Rev 6:1-27, 1990
17. Temple RC, Clark P, Schneider A, Nagi DK, Hendra TJ, Yudkin JS, Hales CN: Radioimmunoassay may overestimate insulin in non-insulin dependent diabetics. Clin Endocrinol 32:689-693, 1990
18. Nagi DK, Knowler WC, Hanson RL, Mohamed Ali V, Yudkin JS: Plasminogen activator inhibitor-(PAI-1) and non-insulin dependent diabetes in Pima Indians, South Asians and Europeans: populations at varying risk of NIDDM and coronary artery disease. Thromb Haemostas 75:921-927, 1996
19. Knowler WC, Bennett PH, Hamman RF, Miller M: Diabetes incidence and prevalence in Pima Indians: a 19 fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108:497-505, 1978
20. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
21. Mohamed-Ali V, Gould MM, Gillies S. Goubet S, Yudkin JS, Haines AP: Association of proinsulin-like molecules with lipids and fibrinogen in nondiabetic subjects: evidence against a modulating role for insulin. Diabetologia 38:1110-1116, 1995
22. Mohamed-Ali V, Nagi DK, Yudkin JS: Sensitive microplate IRMAs for intact and des 31,32 proinsulin compared with HPLC and cellulose IRMAs. Clin Chem 42:977-979, 1996
23. Heding LG: Radioimmunological determinations of human C-peptide in serum. Diabetologia 11:541-548, 1975
24. Phillips DIW, Clark PM, Hales CN, Osmond C: Understanding oral glucose tolerance: comparison of glucose or insulin measurements during oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11:286-293, 1994
25. Aronoff SL, Bennett PH, Gorden P, Rushforth N, Miller M: Unexplained hyperinsulinemia in normal and "prediabetic" Pima Indians compared with normal whites. Diabetes 26:827-840, 1977
26. Polonsky KS, Rubenstein AH: C-peptide as a measure of the secretion and hepatic extraction of insulin: pitfalls and limitations. Diabetes 33:486-494, 1984
27. Hollenbeck C, Reaven GM: Variations in insulin stimulated glucose uptake in individuals with normal glucose tolerance. J Clin Endocrinol Metab 64:1169-1173, 1987
28. Lillioja S, Mott DM, Zawadzki JK, Young A, Abbot WGH, Knowler WC, Bennett PH, Moll P, Bogardus C: In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes 36:1329-1335, 1987
29. Nagulesparan M, Savage PJ, Knowler WC, Johnson GC, Bennett PH: Increased in vivo insulin resistance in non-diabetic Pima Indians compared with whites. Diabetes 31:952-956, 1982
30. Lillioja S, Nyomba BL, Saad MF, Ferraro R, Castillo C, Bennett PH, Bogardus C: Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. J Clin Endocrinol Metab 73:866-876, 1991
31. Haffner SM, Bowsher RR, Mykkanen L, Hazuda HP, Valdez RA, Gingerich R, Monterossa A, Stern MP: Proinsulin and specific insulin concentrations in high and low risk populations for NIDDM. Diabetes 43:1490-1493, 1994
32. Mykkänen L, Haffner SM, Kuusisto J, Pyörälä K, Hales CN, Laakso M: Serum proinsulin and insulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia 10:1176-1182, 1995
33. Kahn SE, Leonetti DL, Prigeon L, Boyko EJ, Bergstrom RW, Fujimoto WY: Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes 44:173-179, 1995
34. Duckworth WC, Solomon S, Kitabchi AE: Effect of chronic sulphonylurea therapy on plasma insulin and proinsulin levels. J Clin Endocrinol Metab 35:585-591, 1974
35. Davies MJ, Metcalf J, Day JL, Grenfell A, Gray IP, Hales CN: Effect of sulphonylurea therapy on plasma insulin, intact proinsulin, and 32.33 split proinsulin in subjects with type 2 diabetes mellitus. Diabet Med 11:293-298, 1994
36. Birkeland KI, Furuseth K, Melander A, Mowinckel P, Vaaler S: Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide: glycemic control and insulin secretion during 15 months. Diabetes Care 17:45-49, 1994
37. Yoshioka N, Kazuya T, Matsuda A, Iwamoto Y: Effects of dietary treatment on serum insulin and proinsulin response in newly diagnosed NIDDM. Diabetes 38:262-267, 1993
38. Davies MJ, Metcalf J, Day JL, Grenfell A, Hales CN, Gray IP: Improved beta cell function, with reduction in secretion of intact and 32,33 split proinsulin, after dietary intervention in subjects with type-2 diabetes mellitus. Diabet Med 11:71-78, 1994
39. Nagi DK, Mohamed Ali V, Yudkin JS: Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with non-insulin-dependent (type 2) diabetes mellitus. Diabet Med 13:753-757, 1996
40. Jain SK, Nagi DK, Slavin BM, Lumb PJ, Yudkin JS: Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemia. Diabet Med 10:27-32, 1993
41. Davies MJ, Metcalf J, Gray IP, Day JL, Hales CN: Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type 2 diabetes mellitus. Diabet Med 10:305-312, 1993